剖宫产术后并发肺栓塞的危险因素分析
DOI:
作者:
作者单位:

作者简介:

通讯作者:

基金项目:

北京市临床重点专科项目(京卫〔2020〕129号)


Analysis of risk factors of pulmonary embolism after cesarean section
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
    摘要:

    目的 探讨剖宫产术后并发肺栓塞患者的临床特点及相关危险因素,以便于临床及早识别、干预及改善患者预后。方法 纳入本院呼吸与危重症医学科和产科在2018年10月—2024年5月期间的剖宫产术后并发肺栓塞(PE)患者31例为病例组(PE组),随机选取同期未发生PE的62例患者作为对照组(非PE组)。收集两组患者的临床资料包括:一般情况;PE危险因素:年龄≥35岁、孕期增重≥20 Kg、多胎妊娠、产次≥3次、不良孕产史、产程延长≥24 h、辅助生殖技术、妊娠合并免疫机制疾患、重度子痫前期、产后出血(≥1000 mL)需要输血、产后感染、高脂血症、早产/胎死宫内/阴道助产等;实验室检查:加压静脉超声成像(CUS)、肺动脉CT造影检查(CTPA)、血红蛋白(HGB)、C反应蛋白(CRP)、白蛋白(ALB)、B型钠尿肽(BNP)、肌钙蛋白I(TNI)、D-二聚体(D-DIMER)、纤维蛋白原(FBG)等。采用二元Logistic回归模型确定剖宫产术后发生PE的独立危险因素。应用受试者工作特征曲线(ROC)研究影响因素诊断剖宫产术后PE的最佳临界值及联合检测效能。结果 剖宫产术后PE的发病时间平均为(2.19±2.01)d。剖宫产术后PE组患者年龄、CRP、D-DIMER和FBG水平,产后感染发生率较非PE组高,差异均具有统计学意义(P<0.05);剖宫产术后PE组HGB和ALB水平较非PE组低,差异均具有统计学意义(P<0.05)。高龄(OR=2.233,P=0.020)、产后感染(OR=1.187,P=0.032)和ALB≤35 g/L(OR=3.761,P=0.001)是剖宫产术后发生PE的独立危险因素。高龄、产后感染和ALB联合检测诊断剖宫产术后发生PE的ROC曲线下面积和95%CI 是0.803(0.716—0.890),敏感度为90.0%。结论 剖宫产术是PE的高危因素,高龄、产后感染和ALB≤35 g/L是剖宫产术后PE的独立危险因素,三者联合检测对剖宫产术后并发PE具有一定的预测价值

    Abstract:

    Objective To investigate the clinical characteristics and related risk factors of patients with pulmonary embolism after cesarean section, so as to facilitate early clinical identification, intervention and improve prognosis. Methods A total of 31 patients who developed pulmonary embolism (PE) after cesarean section in the Department of Respiratory and Critical Care Medicine and the Department of Obstetrics of our hospital from October 2018 to May 2024 were included as the case group (PE group), and 62 patients who did not develop PE during the same period were randomly selected as the control group (non-PE group). The clinical data of the two groups were collected, including: general conditions; PE risk factors (age ≥ 35 years old, pregnancy weight gain ≥ 20 kg, multiple pregnancies, number of pregnancies ≥ 3 times, adverse pregnancy history, prolonged labor ≥ 24 hours, assisted reproductive technology, pregnancy with immune mechanism disorders, severe preeclampsia, postpartum hemorrhage(≥1000 ml)requiring blood transfusion, postpartum infection, hyperlipidemia, preterm birth/fetal death in utero/vaginal assisted delivery, etc.); laboratory tests (pressure venous ultrasound imaging (CUS), pulmonary artery CT angiography (CTPA), hemoglobin (HGB), C-reactive protein (CRP), albumin (ALB), B-type natriuretic peptide (BNP), troponin I (TNI), D-dimer (D-DIMER), fibrinogen (FBG)). A binary Logistic regression model was used to determine the independent risk factors for PE after cesarean section. The receiver operating characteristic curve (ROC) was applied to study the optimal critical value for diagnosing PE after cesarean section and the combined detection efficacy of influencing factors. Results The average onset time of PE after cesarean section was (2.19±2.01) days. After cesarean section, the age, CRP, D-Dimer and Fbg levels in PE group were higher than those in non-PE group, and the positive rate of the incidence of postpartum infection were higher than those in non-PE group, with statistical significance (P<0.05). After cesarean section, the levels of HGB and ALB in PE group were lower than those in non-PE group, and the differences were statistically significant (P<0.05). Advanced age(OR=2.233,P=0.020),postpartum infection (OR=1.187,P=0.032) and ALB≤35g/L (OR=3.761,P=0.001) were independent risk factors for PE after cesarean section. The area under ROC curve and 95%CI of combined detection for diagnosing PE after cesarean section were 0.803 (0.716-0.890), and the sensitivity was 90.0%. Conclusion Cesarean section is a high-risk factor for PE. Advanced age,postpartum infection and ALB≤35g/L are independent risk factors for PE after cesarean section. Triple joint detection has a certain predictive value for for PE after cesarean section

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-05-19
您是第位访问者
网站版权所有:《西部医学》编辑部     蜀ICP备18038379号-4
地址:四川省成都市武侯区小天竺街75号财富国际18F-1号    邮政编码:610041
电话:028-85570072/85588403 本网站支持 IPv6    E-mail:xbyxqk@163.com
技术支持:北京勤云科技发展有限公司